The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner ...

No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the incorporation of Pathway Maps in OFF-X, a cutting-edge translational safety intelligence ...

Adapting to uncertainty over product review timelines at FDA could complicate M&A for pharma buyers and sellers, especially ...

Driven by a commitment to achieve excellence since 1955, the Thomas J. Long School of Pharmacy trains pharmacists to excel as ...

By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.

Drug addiction poses a global public health challenge, with limited therapeutic options and modest efficacy. While clinical ...

Olutayo Farinde, a synthetic organic and medicinal chemist at the University of Toledo, has disclosed that fast-tracking organic methodology can accelerate a cure.

Using a computational strategy that allows them to combine information from many large datasets, MIT researchers have identified several new potential targets for Alzheimer’s disease.